Chiara Borga
Overview
Explore the profile of Chiara Borga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ceccon C, Borga C, Angerilli V, Bergamo F, Munari G, Sabbadin M, et al.
Pathol Res Pract
. 2024 Dec;
266:155786.
PMID: 39724851
Background: RAS/BRAF mutations, mismatch DNA repair complex deficiency (MMRd)/microsatellite instability (MSI), and CpG methylator phenotype (CIMP) are key molecular actors in colorectal carcinogenesis. To date, conflicting evidence about the correlations...
2.
Angerilli V, Sabella G, Simbolo M, Lagano V, Centonze G, Gentili M, et al.
Br J Cancer
. 2024 May;
131(1):159-170.
PMID: 38729995
Background: High-grade gastro-entero-pancreatic neoplasms (HG GEP-NENs) can be stratified according to their morphology and Ki-67 values into three prognostic classes: neuroendocrine tumors grade 3 (NETs G3), neuroendocrine carcinomas with Ki-67 ...
3.
Trovarelli G, Sbaraglia M, Angelini A, Bellan E, Pala E, Belluzzi E, et al.
Clin Orthop Relat Res
. 2024 Jan;
PMID: 38170705
Background: Because chondrosarcomas vary widely in their behavior, and because anticipating their behavior based on histology alone can be challenging, genetic markers represent an appealing area of inquiry that may...
4.
Rizzato M, Brignola S, Munari G, Gatti M, Dadduzio V, Borga C, et al.
Eur J Cancer
. 2022 Mar;
166:165-175.
PMID: 35303508
Aim: FGFR2 rearrangements have been identified as a novel therapeutic target of biliary tract cancer (BTC). However, reliable prevalence estimates of this molecular alteration and its prognostic role have not...
5.
Sciammarella C, Bencivenga M, Mafficini A, Piredda M, Tsvetkova V, Paolino G, et al.
Appl Immunohistochem Mol Morphol
. 2021 Sep;
30(2):145-152.
PMID: 34483242
Mixed neuroendocrine/non-neuroendocrine neoplasms (MiNEN) are rare mixed epithelial neoplasms in which a neuroendocrine component is combined with a non-neuroendocrine component. Here, we provide the clinical, pathologic, and molecular report of...
6.
Borga C, Dal Pozzo C, Trevellin E, Bergamo F, Murgioni S, Milanetto A, et al.
Endocr Relat Cancer
. 2021 May;
28(7):449-456.
PMID: 33974555
The knowledge of the molecular landscape of ileal neuroendocrine tumors (NETs) is affected by the lack of systematic studies investigating intra-tumoral heterogeneity. In this study, intra-tumoral heterogeneity was investigated in...
7.
Munari G, Businello G, Mattiolo P, Pennelli G, Sbaraglia M, Borga C, et al.
J Cancer Res Clin Oncol
. 2021 Mar;
147(7):1897-1904.
PMID: 33712927
Purpose: Non-neuroendocrine neoplasms of the appendix are a phenotypically heterogeneous group of lesions; a comprehensive molecular characterization of these tumors is still lacking. Methods: A total of 52 samples taken...
8.
Borga C, Businello G, Murgioni S, Bergamo F, Martini C, De Carlo E, et al.
Curr Treat Options Oncol
. 2021 Feb;
22(4):29.
PMID: 33641005
The clinical scenario of gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) is continuously changing due to significant improvements in the definition of their molecular landscapes and the introduction of innovative therapeutic approaches. Many...
9.
Fassan M, Milione M, Maddalena G, Cremolini C, Schirripa M, Pietrantonio F, et al.
Eur J Cancer
. 2021 Feb;
146:145-154.
PMID: 33607478
Background: Neuroendocrine differentiation has been extensively associated with worse prognosis and to mechanisms of therapy resistance in several epithelial cancers. A high prevalence of neuroendocrine differentiation was recently described in...
10.
Gil-Gomez G, Fassan M, Nonell L, Garrido M, Climent M, Anglada R, et al.
Dis Esophagus
. 2021 Feb;
34(7).
PMID: 33558874
Background: Cardiac-type epithelium has been proposed as the precursor of intestinal metaplasia in the development of Barrett's esophagus. Dysregulation of microRNAs (miRNAs) and their effects on CDX2 expression may contribute...